Effects of ramipril in nondiabetic nephropathy: improved parameters of oxidatives stress and potential modulation of advanced glycation end products. (Q44401494)

From Wikidata

Jump to navigation Jump to search

scientific article published in April 2003

Language	Label	Description	Also known as
English	Effects of ramipril in nondiabetic nephropathy: improved parameters of oxidatives stress and potential modulation of advanced glycation end products.	scientific article published in April 2003

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692571%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Effects of ramipril in nondiabetic nephropathy: improved parameters of oxidatives stress and potential modulation of advanced glycation end products (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692571%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

based on heuristic

inferred from title

Katarína Sebekova

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692571%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

Gazdíková K

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692571%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Syrová D

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692571%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Blazícek P

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692571%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Schinzel R

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692571%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Heidland A

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692571%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Spustová V

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692571%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Dzúrik R

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692571%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 April 2003

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692571%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Journal of Human Hypertension

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692571%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692571%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692571%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

265-270

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12692571%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

https://scigraph.springernature.com/pub.10.1038/sj.jhh.1001541

0 references

Plasma levels of advanced glycation end products in children with renal disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001541

21 January 2018

Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001541

21 January 2018

Lipid and lipoprotein modification by advanced glycosylation end-products: role in atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001541

21 January 2018

Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: biochemical mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001541

21 January 2018

Effects of ACE inhibition on left ventricular failure and oxidative stress in Dahl salt-sensitive rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001541

21 January 2018

Regulation of glutamine synthetase, aspartokinase, and total protein turnover in Klebsiella aerogenes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001541

21 January 2018

Immune system dysregulation in uremia: role of oxidative stress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001541

21 January 2018

Advanced protein glycosylation in diabetes and aging

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001541

21 January 2018

Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001541

21 January 2018

Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis - amelioration by liver transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001541

21 January 2018

Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001541

21 January 2018

Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001541

7 January 2021

based on heuristic

inferred from DOI database lookup

Technical note. The serum concentration of the advanced glycation end-product N epsilon-(carboxymethyl)lysine is increased in uremia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001541

7 January 2021

based on heuristic

inferred from DOI database lookup

Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001541

7 January 2021

based on heuristic

inferred from DOI database lookup

Homocysteine and atherothrombosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001541

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced oxidation protein products as a novel marker of oxidative stress in uremia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001541

7 January 2021

based on heuristic

inferred from DOI database lookup

Antioxidant effects of angiotensin-converting enzyme (ACE) inhibitors: free radical and oxidant scavenging are sulfhydryl dependent, but lipid peroxidation is inhibited by both sulfhydryl- and nonsulfhydryl-containing ACE inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001541

7 January 2021

based on heuristic

inferred from DOI database lookup

Enalapril and captopril enhance glutathione-dependent antioxidant defenses in mouse tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001541

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipid peroxidation and activities of antioxidant enzymes in the diabetic kidney: effect of treatment with angiotensin convertase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001541

7 January 2021

based on heuristic

inferred from DOI database lookup

Formation of plasma advanced glycosylation end products (AGEs) has no influence on plasma viscosity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001541

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced glycation end products and their recognition by macrophage and macrophage-derived cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001541

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced glycation end products in end-stage renal disease and their removal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001541

7 January 2021

based on heuristic

inferred from DOI database lookup

Advanced glycation end-product levels in subtotally nephrectomized rats: beneficial effects of angiotensin II receptor 1 antagonist losartan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001541

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of human peripheral monocytes by angiotensin II

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001541

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001541

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44401494&oldid=1519058358"